Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs Transparent Meds

PlexusDx
Graded #162

Higher grade

vs+5.800000000000004
Transparent Meds
Graded #284

Lower grade

The verdict

PlexusDx takes it — 67.7/100 to 61.9/100.

PlexusDx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +31
74
43
Dose & formulationTransparent Meds +13
64
77
Clinical oversightTransparent Meds +5
74
79
Labs & monitoringEven
52
52
FulfillmentPlexusDx +4
78
74
Contract termsPlexusDx +14
55
41
PlexusDx · left barTransparent Meds · right bar

The numbers

MetricPlexusDxTransparent Meds
WeighScore67.7/10061.9/100
GradeCC
Scorecard rank#162#284
Semaglutide$149/mo (starting dose, compounded)$229/mo (promotional rate, compounded)
Tirzepatide$249/mo (starting dose, compounded)$349/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
PlexusDx

Graded #162 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted
Transparent Meds

Graded #284 · C

Strengths

  • Transparent, upfront monthly pricing — intro $149/mo for compounded semaglutide and $249/mo for tirzepatide (regular $229 / $349)
  • Clean, modern telehealth experience with a quick eligibility quiz and clinician review before any prescription
  • HIPAA-compliant and displays a LegitScript-style verification seal

Where it loses points

  • Headline prices are intro first-month fees — the regular monthly cost is higher ($229 semaglutide, $349 tirzepatide)
  • Connector model that pairs you with licensed providers; it doesn't name its compounding pharmacy
  • Doesn't publish the states it serves, so confirm availability before signing up
  • Compounded semaglutide and tirzepatide injections only — no oral, brand-name, or insurance options

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard